2006-2018 年 Medicaid 长效胰岛素价格、市场份额和支出趋势。
Trends in Medicaid Prices, Market Share, and Spending on Long-Acting Insulins, 2006-2018.
机构信息
Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania.
Insurance Services Division, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
出版信息
JAMA. 2019 Apr 23;321(16):1627-1629. doi: 10.1001/jama.2019.2990.
Abstract
This study uses Medicaid drug utilization data to describe reimbursement and market share of long-acting insulins before and after approval of new insulin products and to estimate savings associated with a “biosimilar” for insulin glargine approved in 2015.
摘要
本研究利用医疗补助药物利用数据，描述新胰岛素产品获批前后长效胰岛素的报销情况和市场份额，并估算 2015 年获批的甘精胰岛素“生物类似药”相关节省。
相似文献
1
Trends in Medicaid Prices, Market Share, and Spending on Long-Acting Insulins, 2006-2018.2006-2018 年 Medicaid 长效胰岛素价格、市场份额和支出趋势。
JAMA. 2019 Apr 23;321(16):1627-1629. doi: 10.1001/jama.2019.2990.
2
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications.在欧洲，包括生物类似药在内的长效胰岛素类似物的使用趋势：发现与启示。
Biomed Res Int. 2021 Oct 11;2021:9996193. doi: 10.1155/2021/9996193. eCollection 2021.
3
Differences Between Managed Care and Fee-for-Service Medicaid in the Use of Generics for High-Rebate Drugs: The Cases of Insulin Glargine and Glatiramer.管理式医疗与按服务收费的医疗补助制度在高回扣药物使用仿制药方面的差异：以甘精胰岛素和格拉替雷为例。
J Manag Care Spec Pharm. 2020 Feb;26(2):154-159. doi: 10.18553/jmcp.2020.26.2.154.
4
Ongoing efforts to improve the management of patients with diabetes in Bangladesh and the implications.孟加拉国持续努力改善糖尿病患者管理及其影响。
Hosp Pract (1995). 2021 Oct;49(4):266-272. doi: 10.1080/21548331.2021.1906083. Epub 2021 Apr 28.
5
Trends in Medicaid Reimbursements for Insulin From 1991 Through 2014.1991 年至 2014 年医疗补助计划胰岛素报销趋势。
JAMA Intern Med. 2015 Oct;175(10):1681-6. doi: 10.1001/jamainternmed.2015.4338.
6
Trends in List Prices, Net Prices, and Discounts for Originator Biologics Facing Biosimilar Competition.生物类似药竞争下的原研生物药品目录价格、净价和折扣趋势。
JAMA Netw Open. 2019 Dec 2;2(12):e1917379. doi: 10.1001/jamanetworkopen.2019.17379.
7
Real-World Budget Impact of the Adoption of Insulin Glargine Biosimilars in Primary Care in England (2015-2018).英格兰初级医疗中采用甘精胰岛素生物类似药的真实世界预算影响（2015 - 2018年）
Diabetes Care. 2020 Aug;43(8):1767-1773. doi: 10.2337/dc19-2395. Epub 2020 Jun 11.
8
Twenty years of triptans in the United States Medicaid programs: Utilization and reimbursement trends from 1993 to 2013.美国医疗补助计划中曲坦类药物使用二十年：1993年至2013年的使用情况及报销趋势
Cephalalgia. 2016 Dec;36(14):1305-1315. doi: 10.1177/0333102416629237. Epub 2016 Feb 3.
9
The price paradox of biosimilar-like long-acting insulin.生物类似长效胰岛素的价格悖论。
Am J Manag Care. 2022 Nov 1;28(11):e405-e410. doi: 10.37765/ajmc.2022.89265.
10
Changes Associated With the Entry of a Biosimilar in the Insulin Glargine Market.胰岛素甘精类似物进入市场相关的变化。
JAMA Intern Med. 2021 Oct 1;181(10):1405-1407. doi: 10.1001/jamainternmed.2021.2769.
引用本文的文献
1
Recommendations for Interchangeability in a Growing Biosimilar Market in Latin America.拉丁美洲日益增长的生物类似药市场中的可互换性建议。
Adv Ther. 2024 Dec;41(12):4357-4368. doi: 10.1007/s12325-024-02990-y. Epub 2024 Oct 9.
2
Impact of list price changes on out-of-pocket costs and adherence in four high-rebate specialty drugs.四种高回扣专科药物的标价变化对自付费用和依从性的影响。
PLoS One. 2023 Jan 19;18(1):e0280570. doi: 10.1371/journal.pone.0280570. eCollection 2023.
3
Prescriber Perspectives on Biosimilar Adoption and Potential Role of Clinical Pharmacology: A Workshop Summary.《关于生物类似药采用的处方医生观点和临床药理学的潜在作用：研讨会总结》。
Clin Pharmacol Ther. 2023 Jan;113(1):37-49. doi: 10.1002/cpt.2765. Epub 2022 Nov 4.
4
Estimation of the Share of Net Expenditures on Insulin Captured by US Manufacturers, Wholesalers, Pharmacy Benefit Managers, Pharmacies, and Health Plans From 2014 to 2018.2014 年至 2018 年期间，美国制造商、批发商、药品福利经理、药店和健康计划捕获的胰岛素净支出份额估计。
JAMA Health Forum. 2021 Nov 5;2(11):e213409. doi: 10.1001/jamahealthforum.2021.3409. eCollection 2021 Nov.
5
Real-World Impact of Switching From Insulin Glargine (Lantus) to Basaglar and Potential Cost Saving in a Large Public Healthcare System in Saudi Arabia.在沙特阿拉伯的大型公共医疗体系中，从甘精胰岛素（来得时）切换到贝塔西拉（Basaglar）的实际影响和潜在成本节约。
Front Public Health. 2022 Jun 13;10:852721. doi: 10.3389/fpubh.2022.852721. eCollection 2022.
6
Consequences of forgoing prescription drug subsidies among low-income Medicare beneficiaries with diabetes.放弃处方药物补贴对患有糖尿病的低收入医疗保险受益人的影响。
Health Serv Res. 2022 Oct;57(5):1136-1144. doi: 10.1111/1475-6773.13990. Epub 2022 Apr 27.
7
Barriers to Uptake of Insulin Technologies and Novel Solutions.胰岛素技术应用的障碍及新解决方案
Med Devices (Auckl). 2021 Nov 12;14:339-354. doi: 10.2147/MDER.S312858. eCollection 2021.
8
Trends in Insulin Types and Devices Used by Adults With Type 2 Diabetes in the United States, 2016 to 2020.美国 2016 至 2020 年 2 型糖尿病成人使用的胰岛素类型和装置的趋势。
JAMA Netw Open. 2021 Oct 1;4(10):e2128782. doi: 10.1001/jamanetworkopen.2021.28782.
9
A Decade of Disparities in Diabetes Technology Use and HbA in Pediatric Type 1 Diabetes: A Transatlantic Comparison.糖尿病技术使用和儿童 1 型糖尿病 HbA1c 方面的十年差异：跨大西洋比较。
Diabetes Care. 2021 Jan;44(1):133-140. doi: 10.2337/dc20-0257. Epub 2020 Sep 16.
10
Differences Between Managed Care and Fee-for-Service Medicaid in the Use of Generics for High-Rebate Drugs: The Cases of Insulin Glargine and Glatiramer.管理式医疗与按服务收费的医疗补助制度在高回扣药物使用仿制药方面的差异：以甘精胰岛素和格拉替雷为例。
J Manag Care Spec Pharm. 2020 Feb;26(2):154-159. doi: 10.18553/jmcp.2020.26.2.154.
本文引用的文献
1
Assessment of Price Changes of Existing Tumor Necrosis Factor Inhibitors After the Market Entry of Competitors.评估竞争对手进入市场后现有肿瘤坏死因子抑制剂的价格变化。
JAMA Intern Med. 2019 May 1;179(5):713-716. doi: 10.1001/jamainternmed.2018.7656.
2
Expenditures and Prices of Antihyperglycemic Medications in the United States: 2002-2013.美国降糖药物的支出与价格：2002 - 2013年
JAMA. 2016 Apr 5;315(13):1400-2. doi: 10.1001/jama.2016.0126.
3
Trends in Medicaid Reimbursements for Insulin From 1991 Through 2014.1991 年至 2014 年医疗补助计划胰岛素报销趋势。
JAMA Intern Med. 2015 Oct;175(10):1681-6. doi: 10.1001/jamainternmed.2015.4338.
4
Why is there no generic insulin? Historical origins of a modern problem.为什么没有通用胰岛素？一个现代问题的历史根源。
N Engl J Med. 2015 Mar 19;372(12):1171-5. doi: 10.1056/NEJMms1411398.
Zotero 插件